Chimerix's IPO

Chimerix raised a round of funding on April 11, 2013. Investors include Public.

Chimerix is developing antiviral therapeutics with the potential to transform patient care in multiple settings, including transplant, oncology, acute care and global health. Based on lipid conjugate …

Articles about Chimerix's IPO: